Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, October 7, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Puneet Souda Maintained (TWST) at Hold with Decreased Target to $45 on, Oct 7th, 2022
Puneet Souda of SVB Leerink, Maintained "Twist Bioscience Corporation" (TWST) at Hold with Decreased Target from $50 to $45 on, Oct 7th, 2022.
Puneet has made no other calls on TWST in the last 4 months.
There is 1 other peer that has a rating on TWST. Out of the 1 peers that are also analyzing TWST, 0 agree with Puneet's Rating of Hold.
This is the rating of the analyst that currently disagrees with Puneet
- Luke Sergott of "Barclays" Maintained at Buy with Decreased Target to $45 on, Thursday, October 6th, 2022
